ANDA 208005, held by Mylan. Fingolimod Hydrochloride.
As of Nov 16, 2026, ANDA 208005 (Fingolimod Hydrochloride), held by Mylan, was first approved by FDA on Jan 19, 2021, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 19, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fingolimod HydrochlorideEQ 0.5MG BASE · capsule;oral | Fingolimod Hydrochloride | Discontinued |
| Apr 15, 2024 | Supplement 4Labeling · Standard review | Approved | None posted |
| Apr 15, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 19, 2021 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters